Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of IBI363 in Subjects with Advanced Solid MalignanciesDigestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, kidney cancer, kidney disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, rectal disorder, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, urinary system disorderRecruitingPhase 22024-12-19NCT06281678

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Innovent Biologics (Suzhou) Co. Ltd.82

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BRCR Medical CenterPlantationUnited States6
Fred Hutchinson Cancer CenterSeattleUnited States250
MD Anderson Cancer Center-University of TexasHoustonUnited States1
Michigan Hematology & Oncology Consultants - MedOnc DearbornDearbornUnited States1
Michigan Hematology & Oncology Consultants - MedOnc TroyTroyUnited States1
Ocala Oncology CenterOcalaUnited States9
Oncology Consultants P.A.HoustonUnited States8
University of California, San Francisco (UCSF)San FranciscoUnited States12
University of Kansas Medical Center (KUMC)FairwayUnited States1